Item 2.02 - Results of Operations and Financial Condition: The filing reports Cognizant's financial results and operational performance as of July 29, 2026 Item 7.01 - Regulation FD Disclosure: The company is making additional disclosures in compliance with Regulation Fair Disclosure requirements Item 9.01 - Financial Statements and Exhibits: The filing includes financial statements and exhibits…

Our analysis rates this filing CAUTIOUS. Cognizant presents a cautious picture with elevated but not critical concerns. The primary issue is a significant deceleration in organic revenue growth (45% slowdown YoY) coupled with downward guidance revision, which signals management expects continued…

Concern level: ELEVATED (5.8/10). Key factors: Revenue growth deceleration: Q2 2026 organic growth of 4.5% YoY represents a 45% slowdown from 8.1% YoY in Q2 2025, indicating material loss of momentum; Guidance reduction: Full-year 2026 constant currency revenue growth guidance revised downward to 4.0-5.5%, signaling management expects continued deceleration through year-end; Margin expansion…

Notable risk changes: Q2 2026 revenue growth decelerated to 4.5% YoY (from 8.1% in Q2 2025) - significant slowdown in organic growth momentum; Full-year 2026 constant currency revenue guidance revised downward to 4.0-5.5% (from prior guidance range), indicating management expects continued deceleration; Operating margin expansion modest at 30 bps YoY (15.9% vs 15.6%), below adjusted margin guidance of 16.0%,…

No earnings surprise data disclosed in this 8-K cover document.

The model predicts CTSH will underperform the S&P 500 by about 0.0% over 30 days (model confidence 65%). This is model analysis for research, not investment advice.